Clint Brauer grew up on his family's Kansas farm. His dad sprayed the same chemicals every American farmer sprays. Years later: Parkinson's. Clint walked away from a tech career to build a different way. Today his company, Greenfield Robotics, runs a patented fleet of autonomous bots that slice weeds with centimeter precision, day or night, herbicide-free. 

Greenfield is now opening shares to everyday investors under Reg A+. Reserve during Test the Waters and you lock in a 5% bonus that can grow to 20% the week the round goes live. The US has 250 million acres at stake.

Get Bonus Shares

_{Greenfield Robotics is Testing The Waters under tier 2 of Regulation A. No money or other consideration is being solicited, and if sent in response will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement filed by the company with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification. An indication of interest involves no obligation or commitment of any kind. “Reserving” shares is simply an indication of interest. There is no binding commitment for investors that reserve shares in this manner to ultimately invest and purchase the shares reserved of the company, or to purchase any shares of the company whatsoever.}

After Wednesday's sharp sell-off, Indian markets found their footing.

The Nifty 50 climbed back to 23,962.80 (+0.34%), while the Sensex gained 0.31% to close at 76,741.82. The Bank Nifty outperformed the broader market, rising 0.90% to 57,252.45, indicating renewed strength in banking stocks.

The recovery wasn't broad-based across every sector, but investors stepped back into quality names after the previous session's heavy decline. Market sentiment remained cautious as participants balanced improving domestic buying with global geopolitical concerns and the beginning of the corporate earnings season.

Institutional participation continued to provide support to the market.

Positive inflows from both foreign and domestic investors helped stabilize sentiment following the previous day's correction.

Sector performance reflected a defensive approach.

Healthcare and Pharma emerged as the day's strongest performers as investors preferred relatively stable businesses amid global uncertainty. Meanwhile, the IT sector underperformed ahead of major quarterly earnings announcements.

Global markets continued monitoring fresh geopolitical developments in the Middle East, keeping risk appetite in check.

At the same time, investors shifted attention toward India's Q1 earnings season, with TCS officially kicking off the reporting cycle after market hours.

The pharmaceutical giant declined sharply after delaying commercial supplies of semaglutide because of an API-related issue.

The development reminded investors that even companies operating in attractive long-term healthcare themes remain vulnerable to execution and supply-chain challenges.

Despite the weakness in Dr. Reddy's, the broader Healthcare sector still finished among the day's top performers.

Technology investors now have their attention firmly on the IT sector as TCS released its Q1 FY27 results after market close.

Management commentary on global technology spending, client demand, and artificial intelligence investments could influence sentiment across the broader IT industry in the coming sessions.

Today's recovery suggests that investors were willing to buy after Wednesday's sharp decline rather than continue selling.

Positive institutional inflows and strength in Banking and Healthcare helped lift the indices, even as geopolitical uncertainty remained a key risk.

At the same time, the market's focus is beginning to shift from macro events toward corporate earnings, which are likely to drive stock-specific moves over the coming weeks.

Markets will closely monitor:

Every trading day brings new opportunities—but understanding why markets moved matters more than simply knowing that they moved.

Thanks for reading All You Need Markets — Markets & Startups in 3 Minutes.

If you found today's edition valuable, share it with a friend or colleague and subscribe to stay ahead of the markets.